<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01280578</url>
  </required_header>
  <id_info>
    <org_study_id>RESPONDER</org_study_id>
    <nct_id>NCT01280578</nct_id>
  </id_info>
  <brief_title>The Coherex FlatStent™ EF PFO Migraine Registry</brief_title>
  <official_title>The Coherex PFO Migraine Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coherex Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coherex Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, single arm, multicenter clinical registry evaluating the change in migraine
      headaches in migraine with aura patients who undergo patent foramen ovale (PFO) closure with
      the Coherex FlatStent™ EF PFO Closure System.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of enrollment
  </why_stopped>
  <start_date type="Actual">February 1, 2011</start_date>
  <completion_date type="Actual">June 1, 2012</completion_date>
  <primary_completion_date type="Actual">June 1, 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy</measure>
    <description>Percentage of subjects treated with the FlatStent EF who, achieve a clinically significant reduction in migraine or probable migraine headache days at follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Closure efficacy</measure>
    <description>Degree of closure of PFO at follow-up</description>
  </secondary_outcome>
  <enrollment type="Actual">3</enrollment>
  <condition>Patients With Migraine and PFO</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcatheter PFO Closure</intervention_name>
    <description>Transcatheter PFO Closure</description>
    <other_name>Coherex FlatStent™ EF PFO Closure System</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        NA. Study terminated
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Major Inclusion Criteria:

        Age 18-65 males and non pregnant females History of refractory migraine Documented PFO

        Major Exclusion Criteria:

        Known allergy to aspirin or nickel. Medication Overuse Headache Body mass index &gt; 40.
        Recent Botulinum neurotoxin type A treatment Other known structural heart disease, coronary
        artery disease, atrial fibrillation PFO morphology not suitable for FlatStent EF Patients
        who have had a stroke within the past two months Post-traumatic headache. Patients with
        diagnosed hypercoagulable states that require chronic treatment with warfarin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2011</study_first_submitted>
  <study_first_submitted_qc>January 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2011</study_first_posted>
  <last_update_submitted>June 26, 2017</last_update_submitted>
  <last_update_submitted_qc>June 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Migraine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

